Glucagon-like peptide-1 receptor agonists modestly reduced blood pressure among patients with and without diabetes mellitus: A meta-analysis and meta-regression
(1939) 18(3):233-246,1939 Tsao G
CrossRef Increase in relative skeletal muscle mass over time and its inverse association with metabolic syndrome development: a 7-year retrospective cohort study Gyuri Kim, Seung-Eun Lee, Ji Eun Jun, You-Bin Lee, Jiyeon Ahn, Ji Cheol Bae, Sang-Man Jin, Kyu Yeon Hur, Jae Hwan Jee, Moon-Kyu Lee, Jae Hyeon Kim Cardiovascular Diabetology.2018;[Epub] CrossRef Myricetin-induced brown adipose tissue activation prevents obesity and insulin resistance in db/db mice Tao Hu, Xiaoxue Yuan, Gang Wei, Haoshu Luo, Hyuek Jong Lee, Wanzhu Jin European Journal of Nutrition.2018
Principal investigator Subodh Verma, MD, PhD, FRCSC, will present key results from a clinical trial of semaglutide in patients with type 2 diabetes and peripheral artery disease